Navigation Links
Kremers Urban Pharmaceuticals Inc. Settles Concerta® Patent Litigation
Date:9/13/2011

PRINCETON, N.J., Sept. 13, 2011 /PRNewswire/ -- Kremers Urban Pharmaceuticals Inc. is pleased to announce that it has reached a settlement dismissing all pending litigation arising from its Abbreviated New Drug Application (ANDA) to market an extended release methylphenidate hydrochloride product, for which Concerta® is the reference listed drug product. The ANDA is currently under review with FDA.

The settlement includes a patent license and covenant, under existing ALZA Corporation patents under which Kremers Urban may commercially launch its methylphenidate ANDA product on July 1, 2012, or earlier under certain circumstances, pending FDA approval.

About Kremers Urban

Kremers Urban is the generic subsidiary of UCB. It is a specialty generic pharmaceutical company focused on difficult, "high barrier" to entry generic products. To learn more visit www.kremersurban.com.

For More Information Contact:
Antje Witte, Investor Relations
+49 2173 48 1866
antje.witte@ucb.com


'/>"/>
SOURCE Kremers Urban Pharmaceuticals Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1

Related medicine technology :

1. NxStage Medical Founder and CEO Jeffrey Burbank Honored With Mass High Tech All-Star Award
2. CVS Caremark Showcases Workplace and Marketplace Diversity at 2011 National Urban League Conference
3. Surgical Care Affiliates Announces Agreement With Suburban Outpatient Surgery Center
4. NxStage Founder and CEO Jeffrey Burbank Named Ernst & Young Entrepreneur of the Year® 2011 New England Award Winner
5. Teach For America and the Amgen Foundation Renew Partnership to Improve Math and Science Education in Urban and Rural Schools
6. American Heart Association Rapid Access Journal Report: Implanted Monitor Accurately Detects Heart Rhythm Disturbances
7. Bionovos MF101 Shows Statistically Significant Improvement in Sleep Disturbance from Hot Flashes
8. Savient Pharmaceuticals to Present at the Sixth Annual JMP Securities Healthcare Conference
9. Edison Pharmaceuticals, Inc. Closes Financing
10. MD On-Line Acquires Strategic Edge Communications, Expands Provider Offerings to Include Pharmaceuticals
11. Isis Pharmaceuticals to Present at the UBS Global Life Sciences Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/17/2014)... KENNESAW, Ga. and RALEIGH, ... Clinical Trial Marketing Communications, LLC (CTMC), and Integrated ... in patient recruitment and retention for clinical trials ... called Integrated Clinical Trial Marketing Services (i-CTMS). i-CTMS ... and retention services to pharmaceutical, biotechnology and medical ...
(Date:12/15/2014)... , Dec. 12, 2014 Research and Markets ... of the "Inferior Vena Cava (IVC) Filters - ... their offering. http://photos.prnewswire.com/prnh/20130307/600769 ... is projected to reach US$435 million by 2016. The ... 39% (2015) of the global value while ...
(Date:12/15/2014)... BRIDGEWATER, N.J. , Dec. 15, 2014   ... SAN and NYSE: SNY) are collaborating with nationally-recognized patient ... Counts , an awareness program that will gauge how ... risks associated with high LDL-C (bad cholesterol).  American adults ... to take a brief poll and answer a few ...
Breaking Medicine Technology:Integrated Clinical Trial Services and Clinical Trial Marketing Communications Form Joint Venture 2Integrated Clinical Trial Services and Clinical Trial Marketing Communications Form Joint Venture 3Inferior Vena Cava (IVC) Filters - Global Trends, Estimates and Forecasts, 2012-2018 2Inferior Vena Cava (IVC) Filters - Global Trends, Estimates and Forecasts, 2012-2018 3Inferior Vena Cava (IVC) Filters - Global Trends, Estimates and Forecasts, 2012-2018 4Have You Been Counted? Regeneron and Sanofi US Join Forces with Leading Cardiovascular Organizations to Raise Awareness of Cholesterol 2Have You Been Counted? Regeneron and Sanofi US Join Forces with Leading Cardiovascular Organizations to Raise Awareness of Cholesterol 3Have You Been Counted? Regeneron and Sanofi US Join Forces with Leading Cardiovascular Organizations to Raise Awareness of Cholesterol 4Have You Been Counted? Regeneron and Sanofi US Join Forces with Leading Cardiovascular Organizations to Raise Awareness of Cholesterol 5Have You Been Counted? Regeneron and Sanofi US Join Forces with Leading Cardiovascular Organizations to Raise Awareness of Cholesterol 6
... begin Phase IIb study in the first half of ... (Nasdaq: ALSE ), announced today that it has,concluded ... in acute,spinal cord injury (SCI). A total of 48 ... States and Canada. We expect to release periodic,updates of ...
... PHILLIPSBURG, N.J., Jan. 7 Celldex Therapeutics,announced today ... has,granted Fast Track designation to Celldex,s CDX-110 for ... is the most common,and aggressive form of primary ... current therapy. CDX-110 is an immunotherapy that targets,the ...
Cached Medicine Technology:Alseres Pharmaceuticals Concludes Enrollment in the Cethrin(R) Phase I/IIa Clinical Trial in Acute Spinal Cord Injury 2Alseres Pharmaceuticals Concludes Enrollment in the Cethrin(R) Phase I/IIa Clinical Trial in Acute Spinal Cord Injury 3Alseres Pharmaceuticals Concludes Enrollment in the Cethrin(R) Phase I/IIa Clinical Trial in Acute Spinal Cord Injury 4Alseres Pharmaceuticals Concludes Enrollment in the Cethrin(R) Phase I/IIa Clinical Trial in Acute Spinal Cord Injury 5Celldex Therapeutics Receives Fast-Track Designation for CDX-110, a Novel EGFRvIII Vaccine for Glioblastoma 2Celldex Therapeutics Receives Fast-Track Designation for CDX-110, a Novel EGFRvIII Vaccine for Glioblastoma 3Celldex Therapeutics Receives Fast-Track Designation for CDX-110, a Novel EGFRvIII Vaccine for Glioblastoma 4Celldex Therapeutics Receives Fast-Track Designation for CDX-110, a Novel EGFRvIII Vaccine for Glioblastoma 5
(Date:12/17/2014)... HealthDay Reporter , TUESDAY, Dec. ... in America, and work commitment is a big reason why, ... killer," said Dr. Mathias Basner, an assistant professor of sleep ... School of Medicine. A time-use survey of nearly 125,000 ... the main activity exchanged for sleep. Short sleepers -- those ...
(Date:12/15/2014)... 15, 2014 Main Street Dental Team ... weighing in on a new study providing evidence on ... oral hygiene of children. , Sufficient enough evidence already ... as pop or juice drinks, with the onset of ... is whether drinks listed as 100% fruit juice, meaning ...
(Date:12/15/2014)... Health Dialog, a leading provider ... it has received Patient Oriented Accreditation from the ... Disease Management (DM) Programs for asthma, congestive heart ... disease and diabetes. This marks the 12th continuous ... Disease Management (DM) Programs, reaffirming Health Dialog’s focus ...
(Date:12/15/2014)... 15, 2014 Kathy McAfee, America's Marketing ... World Awards in the category of Best Blog 2014. ... for her weekly career blog Networking Ahead ... help professionals elevate their talent and influence through better ... after her book Networking Ahead for Business, has been ...
(Date:12/15/2014)... Bacteroides is becoming the indicator of choice for ... prevalent than coliforms, it cannot reproduce in the presence of ... Key Benefits of the new Bacteroides Sewage Screen:, ... Eliminates false positives from coliforms naturally occurring in the environment ... Maintain the same sampling method with results as quick ...
Breaking Medicine News(10 mins):Health News:Work Steals Valuable Sleep Time, Study Finds 2Health News:Work Steals Valuable Sleep Time, Study Finds 3Health News:Main Street Dental Team, Unionville’s Most Innovative Dental Clinic, Comments on New Study Relating Pure Fruit Juice to Poor Oral Hygiene 2Health News:Health Dialog Receives NCQA Accreditation for Disease Management Programs 2Health News:Kathy McAfee, America’s Marketing Motivator, Wins Best Blog from Women World Awards 2
... (May 1, 2011) -- A drug commonly used to treat ... according to a study published in the May issue of ... kinase inhibitor, blocks the action of mammalian target of rapamycin ... tumor growth. It,s used to treat advanced renal cell carcinoma. ...
... ATHENS, Ohio (April 30, 2011) The Osteopathic Heritage Foundations, ... represents the largest private donation ever given to a college ... to address some of the most pressing health care issues ... of primary care physicians and the diabetes epidemic. The ...
... HealthDay Reporter , FRIDAY, April 29 (HealthDay News) -- ... debate on whether or not American women should begin regular ... the annual meeting of the American Society of Breast ... to 49 with mammograms detected smaller breast cancers, with less ...
... in the emergency department (ED) complaining primarily of lower ... tested for sexually transmitted infections (STIs), according to the ... 30, at the Pediatric Academic Societies (PAS) annual meeting ... when adolescents seek treatment for symptoms suggestive of an ...
... from elevated anxiety. Patient discomfort may cause poor ... Anxiolytic medications are currently used to reduce this ... non-invasive alternative treatment with fewer adverse effects, according to ... Ray Society,s annual meeting. The project was conceived ...
... April 29 (HealthDay News) -- Multiple pregnancies may increase ... plaque in the arteries, suggests new research in mice. ... studied mice late in gestation in either their first ... severe glucose intolerance and excess fat tissue, while those ...
Cached Medicine News:Health News:Renal cancer drug temsirolimus shows promise against mesothelioma 2Health News:Record funding award given to Ohio University College of Osteopathic Medicine 2Health News:Record funding award given to Ohio University College of Osteopathic Medicine 3Health News:Record funding award given to Ohio University College of Osteopathic Medicine 4Health News:Record funding award given to Ohio University College of Osteopathic Medicine 5Health News:Mammograms Can Save Lives of Women in Their 40s: Studies 2Health News:Mammograms Can Save Lives of Women in Their 40s: Studies 3Health News:Mammograms Can Save Lives of Women in Their 40s: Studies 4Health News:EDs should be aware of sexually transmitted infection risk in patients 2Health News:Animal-assisted therapy decreases patient anxiety in pre-MRI setting, study suggests 2
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
Medicine Products: